My 3 top dividend stocks for Christmas

Tucking away some tasty dividends for Christmas can help you to a prosperous New Year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We’re reaching the end of the year and looking back on a tumultuous one — who, in January, would have put money on the UK voting to leave the EU and Donald Trump winning the US presidential election? And we’re reconsidering our investment strategies in the light of all that, aren’t we?

The one strategy that will surely win out over the long run is seeking high-quality shares paying big dividends. Here are three that I think would be great homes for any leftover 2016 investment cash.

Pharmaceuticals rebound

AstraZeneca (LSE: AZN) has been beefing up its development pipeline after the expiry of key patents brought an end to some previous blockbusters. And while that’s been underway, the dividend has been held unchanged at an attractive level.

More optimistic investors had been hoping to see a return to EPS growth in 2017, though that’s now looking more like 2018. But flat earnings for 2015 and 2016 are actually better than the falls predicted, and the slow pace of drugs approvals means a pipeline turnaround isn’t an overnight thing.

The weak share price performance of the past two years has put the prospective dividend yield at a healthy 5%, way ahead of the FTSE 100 average. It’s covered by earnings, albeit not strongly, and the company will surely not cut it now, so close to the earnings turnaround point.

AstraZeneca looks like a great buy for progressive future dividends once earnings growth resumes.

Cash from insurance

If you want a cash cow, it’s hard to think of a better one than Admiral Group (LSE: ADM).

The motor insurance firm has been paying special dividends for years, handing out a total of 114.4p per share in 2015 for a yield of 6.9% on the year-end share price. The firm also told us it has distributed at least 90% of each year’s earnings as dividends since flotation, and that this year it will adjust its dividend balance. That means bigger ordinary dividends and smaller specials, with the same overall effect but perhaps lifting confidence a little.

Analysts expect 6.7% this year and 6.8% next, although boosted a little above earnings by the firm’s ongoing return of surplus capital.

Over the longer term, I expect to see total yields of 5% to 6% per year at today’s share price levels, and that’s got to be worth having — especially from a UK-only business that looks safe from Brexit.

Reliable oil

My third pick is good old reliable Royal Dutch Shell (LSE: RDSB) with its consistent dividends all through the oil price crisis. Bob Dudley of BP said we could be in for at least two or three years of cheap oil, which turned out to be right, and his key message was simply not to panic as things would be back to normal over the long term.

And while smaller oil companies, especially those carrying big debts, have suffered, BP and Shell have been largely untroubled.

Earnings at Shell have dropped for four years in a row, and won’t come close to covering this year’s dividend. But Shell has the cash to keep on paying it, and with a couple of years of recovering earnings forecast now that the OPEC agreement is lifting the price of a barrel again, cover should be back next year.

And a dividend yield of 6.4% is one that’s surely not to be missed.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has recommended AstraZeneca and Royal Dutch Shell. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Night Takeoff Of The American Space Shuttle
Investing Articles

Should I buy Nasdaq stock Micron for my ISA after blowout Q2 earnings?

Nasdaq tech stock Micron is generating incredible revenue growth at the moment amid the AI boom. Yet it still looks…

Read more »

Hand flipping wooden cubes for change wording" Panic" to " Calm".
Investing Articles

Is it time to dump my shares ahead of an almighty stock market crash? Nah!

How should we cope with growing fears of a stock market crash? 'Keep Calm and Carry On' worked in 1939,…

Read more »

Business man pointing at 'Sell' sign
Investing Articles

As the FTSE 100 tanks, consider buying this cheap dividend stock with a 7.3% yield

The FTSE 100 index is in meltdown mode due to the spike in oil prices. This is creating opportunities for…

Read more »

Sun setting over a traditional British neighbourhood.
Investing Articles

UK investors should consider buying shares in Uber. Here’s why

Uber shares could be a great fit for long-term UK investors that are looking to generate capital growth, says Edward…

Read more »

This way, That way, The other way - pointing in different directions
Growth Shares

£1k invested in Rolls-Royce shares at the beginning of the year is currently worth…

Jon Smith points out how well Rolls-Royce shares have done so far in 2026, but issues caution when looking further…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Value Shares

It might not feel like it, but this is the time to think about buying stocks

The FTSE 100 isn’t the first place most investors look for quality growth stocks to consider buying. But Stephen Wright…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

How are Lloyds shares looking in March 2026?

Lloyds shares have taken a tumble in the last month. What has happened? And could this be a golden opportunity…

Read more »

piggy bank, searching with binoculars
Investing Articles

Are Barclays shares really 50% cheaper than HSBC right now?

Barclays shares are trading at a price-to-book ratio half that of rivals like HSBC. Ken Hall looks at what the…

Read more »